Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Protein fragment expressed in E. coli corresponding to amino acids 762-1315.|
|Storage buffer||PBS, pH 7.2|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|ChIP assay (ChIP)||Assay-dependent|
|ELISA (ELISA)||Assay dependent|
|Immunocytochemistry (ICC)||1 ug/ml|
|Immunofluorescence (IF)||1 µg/ml|
|Immunohistochemistry (Paraffin) (IHC (P))||Assay dependent|
|Immunoprecipitation (IP)||Assay dependent|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA1-23160 detects BRCA1 in Human samples. This antibody does not recognize the delta exon 11 splice variant of BRCA1.
MA1-23160 has been successfully used in ELISA, Immunofluorescence, Immunohistochemistry, Immunoprecipitation and Western Blot procedures.
MA1-23160 immunogen corresponds to protein fragment expressed in E. coli corresponding to amino acids 762-1315.
The antigen used to product MA1-23160 has a predicted molecular weight of ~208 kDa.
Store at 4°C short term. For extended storage aliquot and store at -20°C or below. Avoid freeze-thaw cycles.
BRCA1-17F8 recognizes full-length BRCA1, a 220kDa nuclear phosphoprotein, and does not recognize the exon 11 splice variant. In a high proportion of breast and ovarian cancer cell lines, BRCA1 aberrantly mislocates to the cytoplasm. Its usefulness to monitor functional inactivation of BRCA1 in sporadic breast cancers is under active investigation.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
BRCA1/BRCA2-containing complex, subunit 1; breast and ovarian cancer susceptibility protein 1; breast and ovarian cancer sususceptibility protein 1; Breast Cancer 1; Breast Cancer 1 Early Onset; breast cancer 1, early onset; breast cancer associated 1; Breast cancer type 1 susceptibility protein; Breast cancer type 1 susceptibility protein homolog; Breast Ovarian Cancer Susceptibility; early onset breast cancer 1; Fanconi anemia, complementation group S; IRIS; Papillary Serous Carcinoma Of The Peritoneum; protein phosphatase 1, regulatory subunit 53; PSCP; RING finger protein 53; RNF53; truncated BRCA1; truncated breast and ovarian cancer susceptibility protein 1; truncated breast and ovarian cancer sususceptibility protein 1; truncated breast cancer type 1 susceptibility protein
BRCA1; BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53